Can you introduce Órgano Síntesis?

Órgano Síntesis was founded in Mexico in 1966. Since its inception, the company has focused on the production of specialty chemicals for different markets, particularly for the personal care, cosmetics, disinfection, and water treatment markets. Over the past 56 years, we have expanded our product portfolio and have produced more than 120 different products synthesized in our plant located in the municipality of Santiago Tianguistenco, close to the city of Toluca.

We produce industrial actives — mainly biocides and surfactants — in our multipurpose units. We also have a cGMP plant where we manufacture GMP- and USP-quality products registered under the FDA and EPA in US, and the PMDA in Japan. We have exported our products to more than 30 countries, and today our market is mainly in US, Japan, and some Latin American countries.

Órgano Síntesis was acquired by Pilot Chemical Company in 2019. The acquisition has synergized Órgano Síntesis’ technological and commercial strengths, including the expansion of our production of various quaternary ammonium compounds in the Mason® and Maquat® product lines.

In 2022, we launched benzethonium chloride, which Pilot Chemical sells under two brand names, Nobac® and Enhansys®. Our Nobac® BZT USP can be used as an active ingredient in hand hygiene applications like antibacterial hand soaps, and Enhansys® BZT USP can be used as a preservative agent in personal care applications including skin and hair care products. We also launched benzalkonium chloride, under the brand name Nobac® BKC USP, and more recently, chlorphenesin, under the brand name Enhansys® CPH. These new products are cGMP certified and have significantly expanded Pilot Chemical’s portfolio and strengthened its production line in Mexico.

At Órgano Síntesis, we do not manufacture mass-produced products, but rather specialized products; in our laboratory, we can develop products for customers who have more specific needs. In addition, many companies turn to our company to acquire customized production due to our strategic geographic location.

Are you planning to expand your business to other markets?

Pilot Chemical is very strong in surfactants and antibacterial agents; now, with products manufactured in Mexico, we want to increase our market share throughout Latin America. We also want to expand our business in Asia, particularly in Korea, Japan, and Singapore.

What are the main opportunities and challenges for Órgano Síntesis in Mexico?

The main advantages of Mexico are its strategic geographic location with access to two oceans and its proximity to the United States, one of the largest markets in the world. Mexico also has a skilled workforce and numerous trade agreements. In terms of challenges, one of the most important is the supply chain. We need to strengthen our agreements with our main suppliers and make agreements with alternative suppliers. Logistics chains remain a major challenge as well. We need access to more efficient and cost-effective transportation and logistics.

What is your approach to innovation and sustainability?

We have a research center in Mexico that focuses on biocides. We are working to improve our environmental indicators to align with plants in the US. We are also working to ensure that our new products integrate greener and more environmentally friendly technologies.

Within the last three years, Pilot Chemical has taken steps to formalize its commitment to sustainability. The work began in 2020 through a materiality assessment, conducted with extensive engagement with employees and external stakeholders, and was used to develop the company’s sustainability strategy and roadmap, which will guide it in the years ahead. Pilot Chemical’s sustainability strategy includes 11 sustainability goals, which were announced in 2022 in its first Sustainability Report, and against which it will measure and report its progress. These goals are aligned with third-party expertise, including the United Nations Sustainable Development Goals (SDGs), the Global Reporting Initiative (GRI) and the American Chemistry Council (ACC) Responsible Care® program.

Can you tell us about your goals for 2023?

Our priority is to guarantee the highest quality products and provide the best customer service. As an operational objective, it is to maintain maximum safety in our operations, maintain quality standards in our processes and maximum efficiency in the delivery of our products. Finally, our purpose is always to continue with the innovation and development of new products according to customers’ needs to increase our participation in the niche markets we serve.